These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2383524)

  • 21. Dexfenfluramine. Its place in weight control.
    Turner P
    Drugs; 1990; 39 Suppl 3():53-62. PubMed ID: 2197076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of dexfenfluramine treatment in obese adolescents].
    Małecka-Tendera E; Koehler B; Muchacka M; Wazowski R; Trzciakowska A
    Pediatr Pol; 1996 May; 71(5):431-6. PubMed ID: 8710426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour.
    Mathus-Vliegen EM; van de Voorde K; Kok AM; Res AM
    J Intern Med; 1992 Aug; 232(2):119-27. PubMed ID: 1506807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of obesity and major weight reduction on gastric emptying.
    Verdich C; Madsen JL; Toubro S; Buemann B; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2000 Jul; 24(7):899-905. PubMed ID: 10918538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.
    Chow CC; Ko GT; Tsang LW; Yeung VT; Chan JC; Cockram CS
    Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender.
    Teff KL; Alavi A; Chen J; Pourdehnad M; Townsend RR
    Am J Physiol; 1999 Mar; 276(3):R707-14. PubMed ID: 10070130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of fenfluramine and dexfenfluramine in the treatment of obesity: a meta-analysis.
    Carvajal A; García del Pozo J; Martín de Diego I; Rueda de Castro AM; Velasco A
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):285-90. PubMed ID: 11031729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexfenfluramine reduces cardiovascular risk factors.
    Bremer JM; Scott RS; Lintott CJ
    Int J Obes Relat Metab Disord; 1994 Apr; 18(4):199-205. PubMed ID: 8044193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus.
    Horowitz M; Maddox A; Harding PE; Maddern GJ; Chatterton BE; Wishart J; Shearman DJ
    Gastroenterology; 1987 Jun; 92(6):1899-907. PubMed ID: 3569766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of levodopa and metoclopramide on gastric emptying.
    Berkowitz DM; McCallum RW
    Clin Pharmacol Ther; 1980 Mar; 27(3):414-20. PubMed ID: 7357798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity.
    Ditschuneit HH; Flechtner-Mors M; Dolderer M; Fulda U; Ditschuneit H
    Horm Metab Res; 1993 Nov; 25(11):573-8. PubMed ID: 8288160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke.
    Derby LE; Myers MW; Jick H
    Br J Clin Pharmacol; 1999 May; 47(5):565-9. PubMed ID: 10336582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure and plasma norepinephrine responses to dexfenfluramine in obese postmenopausal women.
    Flechtner-Mors M; Ditschuneit HH; Yip I; Adler G
    Am J Clin Nutr; 1998 Apr; 67(4):611-5. PubMed ID: 9537607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects.
    Enç FY; Ones T; Akin HL; Dede F; Turoğlu HT; Ulfer G; Bekiroğlu N; Haklar G; Rehfeld JF; Holst JJ; Ulusoy NB; Imeryüz N
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G482-9. PubMed ID: 19109408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between gastric emptying of solid and caloric liquid meals and alcohol absorption.
    Horowitz M; Maddox A; Bochner M; Wishart J; Bratasiuk R; Collins P; Shearman D
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G291-8. PubMed ID: 2764113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pectin on gastric emptying and gastroduodenal motility in normal subjects.
    Sandhu KS; el Samahi MM; Mena I; Dooley CP; Valenzuela JE
    Gastroenterology; 1987 Feb; 92(2):486-92. PubMed ID: 3539692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexfenfluramine hydrochloride: an anorexigenic agent.
    Bever KA; Perry PJ
    Am J Health Syst Pharm; 1997 Sep; 54(18):2059-72. PubMed ID: 9377205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects.
    Edelbroek MA; Horowitz M; Wishart JM; Akkermans LM
    J Nucl Med; 1993 Apr; 34(4):582-8. PubMed ID: 8455074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of dexfenfluramine in a weight loss program for obese infertile women.
    Galletly C; Clark A; Tomlinson L
    Int J Eat Disord; 1996 Mar; 19(2):209-12. PubMed ID: 8932560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.